Cargando…

A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics

BACKGROUND: Timely diagnosis and classification of colorectal cancer (CRC) are hindered by unsatisfactory clinical assays. Our aim was to construct a blood-based biomarker series using a single assay, suitable for CRC detection, prognostication and staging. METHODS: Serum metabolomic profiles of ade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farshidfar, Farshad, Weljie, Aalim M, Kopciuk, Karen A, Hilsden, Robert, McGregor, S Elizabeth, Buie, W Donald, MacLean, Anthony, Vogel, Hans J, Bathe, Oliver F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046202/ https://www.ncbi.nlm.nih.gov/pubmed/27560555 http://dx.doi.org/10.1038/bjc.2016.243

Ejemplares similares

A quantitative multimodal metabolomic assay for colorectal cancer
por: Farshidfar, Farshad, et al.
Publicado: (2018)

Serum metabolomic profile as a means to distinguish stage of colorectal cancer
por: Farshidfar, Farshad, et al.
Publicado: (2012)

From Genotype to Functional Phenotype: Unraveling the Metabolomic Features of Colorectal Cancer
por: Bathe, Oliver F., et al.
Publicado: (2014)

Distinguishing Benign from Malignant Pancreatic and Periampullary Lesions Using Combined Use of (1)H-NMR Spectroscopy and Gas Chromatography–Mass Spectrometry
por: McConnell, Yarrow J., et al.
Publicado: (2017)

A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolome
por: Amin, Shahil, et al.
Publicado: (2019)

A Framework for Development of Useful Metabolomic Biomarkers and Their Effective Knowledge Translation
por: Marchand, Calena R., et al.
Publicado: (2018)

Metabolism of sleep and aging: Bridging the gap using metabolomics
por: Sengupta, Arjun, et al.
Publicado: (2019)

(1)H-NMR urinary metabolomic profiling for diagnosis of gastric cancer
por: Chan, Angela W, et al.
Publicado: (2016)

Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
por: Huang, Jiaqi, et al.
Publicado: (2016)

Computational Tools for the Secondary Analysis of Metabolomics Experiments
por: Booth, Sean C., et al.
Publicado: (2013)

Performance of variable selection methods using stability-based selection
por: Lu, Danny, et al.
Publicado: (2017)

Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment
por: Hao, Desirée, et al.
Publicado: (2016)

Quantitative (1)H NMR metabolomics reveals extensive metabolic reprogramming of primary and secondary metabolism in elicitor-treated opium poppy cell cultures
por: Zulak, Katherine G, et al.
Publicado: (2008)

Metabolomics reveals differences of metal toxicity in cultures of Pseudomonas pseudoalcaligenes KF707 grown on different carbon sources
por: Booth, Sean C., et al.
Publicado: (2015)

Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia
por: Banoei, Mohammad M., et al.
Publicado: (2017)

Clinical and metabolomic characterization of Brivanib‐Induced hypertension in metastatic colorectal cancer
por: Rattner, Jodi I., et al.
Publicado: (2023)

PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients
por: Harwood, C A, et al.
Publicado: (2008)

Metabolomic Signature of Early Vascular Aging (EVA) in Hypertension
por: Polonis, Katarzyna, et al.
Publicado: (2020)

Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope
por: Ntouroupi, T G, et al.
Publicado: (2008)

Unique volatolomic signatures of TP53 and KRAS in lung cells
por: Davies, M P A, et al.
Publicado: (2014)

Absence of a specific radiation signature in post-Chernobyl thyroid cancers
por: Detours, V, et al.
Publicado: (2005)

Independent and functional validation of a multi-tumour-type proliferation signature
por: Starmans, M H W, et al.
Publicado: (2012)

Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling
por: Zhou, W, et al.
Publicado: (2011)

Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models
por: Ligat, Laetitia, et al.
Publicado: (2015)

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
por: Klimov, Sergey, et al.
Publicado: (2017)

The in situ local immune response, tumour senescence and proliferation in colorectal cancer
por: Roxburgh, C S, et al.
Publicado: (2013)

Satiety Hormone and Metabolomic Response to an Intermittent High Energy Diet Differs in Rats Consuming Long-Term Diets High in Protein or Prebiotic Fiber
por: Reimer, Raylene A., et al.
Publicado: (2012)

Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?
por: McLean, M H, et al.
Publicado: (2013)

Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas
por: Ivanov, S V, et al.
Publicado: (2013)

An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes
por: Pinato, D J, et al.
Publicado: (2014)

Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study
por: Lajer, C B, et al.
Publicado: (2011)

Detection of Merkel cell polyomavirus with a tumour-specific signature in non-small cell lung cancer
por: Hashida, Y, et al.
Publicado: (2013)

Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours
por: Salto-Tellez, M, et al.
Publicado: (2007)

The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma
por: Klimowicz, A C, et al.
Publicado: (2013)

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
por: Sapre, Nikhil, et al.
Publicado: (2016)

A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
por: Bryant, J L, et al.
Publicado: (2012)

Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature
por: D′Amico, L, et al.
Publicado: (2013)

A quantitative metabolomics profiling approach for the noninvasive assessment of liver histology in patients with chronic hepatitis C
por: Sarfaraz, M. Omair, et al.
Publicado: (2016)

Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples
por: Hall, J S, et al.
Publicado: (2011)

Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature
por: Fukumoto, I, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iaalqjtj3osqb1esmitbs8u2ta